Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury

NCT01597635 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01597635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01597635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2012
Completion date
October 6, 2014
Enrollment
44 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

lung injury, acute